With the invent of smart phones, tele-dermatology has become a cheap and cost-effective medium to provide medical services to rural population. Its usefulness is more prominently noted during the COVID 19 pandemic and much more in countries with difficult terrain with limited specialist health providers. Cutaneous leishmaniasis (CL) is a neglected tropical disease which may cause significant disability if treatment is delayed. Here, we discuss three cases of CL from a remote district by use of tele-dermatology during the pandemic lockdown.
CampagnaMNakaFLuJ. Teledermatology: an updated overview of clinical applications and reimbursement policies. Int J Women’s Dermatol2017; 3: 176–179.
2.
de Mello-SampayoF. Patients’ out-of-pocket expenses analysis of presurgical teledermatology. Cost Eff Resour Alloc2019; 17: 1–8.
3.
ZuoKJGuoDRaoJ. Mobile teledermatology: a promising future in clinical practice. J Cutan Med Surg2013; 17: 387–391.
4.
BastolaAShresthaMLamsalM, et al.A case of high altitude cutaneous leishmaniasis in a non-endemic region in Nepal. Parasitol Int2020; 74: 101991.
5.
ParajuliNManandharKDShresthaS, et al.Cutaneous leishmaniasis of lip and role of polymerase chain reaction: a case report. JNMA: J Nepal Med Assoc2020; 58: 494.
6.
ParajuliNAdhikarySKarkiA, et al.Case report: erysipeloid cutaneous leishmaniasis treated with oral miltefosine. Am J Trop Med Hyg2021; 104: 643.
7.
GurelMSTekinBUzunS. Cutaneous leishmaniasis: a great imitator. Clin Dermatol2020; 38: 140–151.
